⏳ Fetching live dividend data...
Home › Calculator › BRTX Dividend Calculator 2026
BioRestorative Therapies, Inc. · NASDAQ
Price: $0.18 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in BRTX → $9.060617810811875e+21M in 10 years · $754,983,801,116,215,000,000,000,000.00/month
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. BioRestorative Therapies, Inc. was incorporated in 1997 and is based in Melville, New York.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open BRTX position with:
Real after-tax yield depends on where you live and how you hold BRTX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1089.32% | 1086.52% | $108,932 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 925.92% | 923.12% | $92,592 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 871.46% | 868.66% | $87,146 / yr |
| 🇬🇧 UK ISA | 0% | 1089.32% | 1086.52% | $108,932 / yr |
| 🇬🇧 UK Taxable | 8.75% | 994.00% | 991.20% | $99,400 / yr |
| 🇨🇦 TFSA | 0% | 1089.32% | 1086.52% | $108,932 / yr |
| 🇨🇦 CA Taxable | 25% | 816.99% | 814.19% | $81,699 / yr |
| 🇦🇺 Super (pension) | 15% | 925.92% | 923.12% | $92,592 / yr |
| 🇦🇺 AU Taxable | 30% | 762.52% | 759.72% | $76,252 / yr |
| 🇩🇪 DE Taxable | 26.375% | 802.01% | 799.21% | $80,201 / yr |
| 🇫🇷 FR Taxable | 30% | 762.52% | 759.72% | $76,252 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
BRTX pays quarterly — 4 times per year. Next ex-div: TBD.
How BRTX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BRTX sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2025-10-06 | 11,719 | $1.60 | $18.8K | ||
| A-Award | 2025-10-06 | 11,719 | $2.75 | $32.2K | ||
| A-Award | 2025-10-06 | 15,625 | $1.60 | $25.0K | ||
| A-Award | 2025-10-06 | 11,719 | $2.75 | $32.2K | ||
| A-Award | 2025-02-14 | 52,632 | $2.46 | $129.5K | ||
| A-Award | 2025-02-14 | 52,632 | $2.46 | $129.5K | ||
| A-Award | 2025-02-14 | 52,632 | $2.46 | $129.5K | ||
| A-Award | 2025-02-14 | 166,492 | $2.46 | $409.6K | ||
| A-Award | 2025-02-14 | 768,979 | $2.46 | $1.89M | ||
| A-Award | 2025-02-14 | 791,885 | $2.46 | $1.95M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BRTX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →